OTCMKTS:HDVY

Health Discovery Competitors

$0.30
-0.04 (-11.94 %)
(As of 07/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.24
$0.40
50-Day Range
$0.04
$0.34
52-Week Range
$0.02
$0.43
Volume11.53 million shs
Average Volume4.54 million shs
Market Capitalization$119.19 million
P/E RatioN/A
Dividend YieldN/A
Beta3.31

Health Discovery (OTCMKTS:HDVY) Vs. ACTG, VHC, PCOA, QTRHF, NTIP, and REFR

Should you be buying HDVY stock or one of its competitors? Companies in the industry of "patent owners & lessors" are considered alternatives and competitors to Health Discovery, including Acacia Research (ACTG), VirnetX (VHC), Pendrell (PCOA), Quarterhill (QTRHF), Network-1 Technologies (NTIP), and Research Frontiers (REFR).

Acacia Research (NASDAQ:ACTG) and Health Discovery (OTCMKTS:HDVY) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

Profitability

This table compares Acacia Research and Health Discovery's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Acacia Research-201.72%-24.48%-10.12%
Health DiscoveryN/A120.67%32.77%

Volatility and Risk

Acacia Research has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, Health Discovery has a beta of 3.31, suggesting that its share price is 231% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Acacia Research and Health Discovery, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acacia Research0000N/A
Health Discovery0000N/A

Insider & Institutional Ownership

60.7% of Acacia Research shares are owned by institutional investors. Comparatively, 0.1% of Health Discovery shares are owned by institutional investors. 1.4% of Acacia Research shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Acacia Research and Health Discovery's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acacia Research$29.78 million9.76$113.44 millionN/AN/A
Health DiscoveryN/AN/A$-760,000.00N/AN/A

Acacia Research has higher revenue and earnings than Health Discovery.

VirnetX (NYSE:VHC) and Health Discovery (OTCMKTS:HDVY) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

Profitability

This table compares VirnetX and Health Discovery's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VirnetX-70,706.16%-20.71%-18.12%
Health DiscoveryN/A120.67%32.77%

Volatility and Risk

VirnetX has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. Comparatively, Health Discovery has a beta of 3.31, suggesting that its share price is 231% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for VirnetX and Health Discovery, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
VirnetX0000N/A
Health Discovery0000N/A

Insider & Institutional Ownership

33.5% of VirnetX shares are owned by institutional investors. Comparatively, 0.1% of Health Discovery shares are owned by institutional investors. 13.8% of VirnetX shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares VirnetX and Health Discovery's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VirnetX$302.64 million0.94$280.43 millionN/AN/A
Health DiscoveryN/AN/A$-760,000.00N/AN/A

VirnetX has higher revenue and earnings than Health Discovery.

Pendrell (OTCMKTS:PCOA) and Health Discovery (OTCMKTS:HDVY) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.

Insider & Institutional Ownership

0.1% of Health Discovery shares are owned by institutional investors. 41.5% of Pendrell shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Volatility and Risk

Pendrell has a beta of -0.26, suggesting that its share price is 126% less volatile than the S&P 500. Comparatively, Health Discovery has a beta of 3.31, suggesting that its share price is 231% more volatile than the S&P 500.

Profitability

This table compares Pendrell and Health Discovery's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PendrellN/AN/AN/A
Health DiscoveryN/A120.67%32.77%

Earnings and Valuation

This table compares Pendrell and Health Discovery's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PendrellN/AN/AN/AN/AN/A
Health DiscoveryN/AN/A$-760,000.00N/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Pendrell and Health Discovery, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pendrell0000N/A
Health Discovery0000N/A

Summary

Health Discovery beats Pendrell on 4 of the 5 factors compared between the two stocks.

Health Discovery (OTCMKTS:HDVY) and Quarterhill (OTCMKTS:QTRHF) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Valuation & Earnings

This table compares Health Discovery and Quarterhill's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health DiscoveryN/AN/A$-760,000.00N/AN/A
Quarterhill$107.89 million2.01$13.95 millionN/AN/A

Quarterhill has higher revenue and earnings than Health Discovery.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Health Discovery and Quarterhill, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Health Discovery0000N/A
Quarterhill00103.00

Quarterhill has a consensus price target of $4.00, indicating a potential upside of 110.53%. Given Quarterhill's higher possible upside, analysts clearly believe Quarterhill is more favorable than Health Discovery.

Risk & Volatility

Health Discovery has a beta of 3.31, suggesting that its share price is 231% more volatile than the S&P 500. Comparatively, Quarterhill has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500.

Insider & Institutional Ownership

0.1% of Health Discovery shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Health Discovery and Quarterhill's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Health DiscoveryN/A120.67%32.77%
Quarterhill13.07%3.91%3.45%

Summary

Quarterhill beats Health Discovery on 5 of the 9 factors compared between the two stocks.

Network-1 Technologies (NYSEAMERICAN:NTIP) and Health Discovery (OTCMKTS:HDVY) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Insider & Institutional Ownership

17.8% of Network-1 Technologies shares are held by institutional investors. Comparatively, 0.1% of Health Discovery shares are held by institutional investors. 30.7% of Network-1 Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations for Network-1 Technologies and Health Discovery, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Network-1 Technologies0000N/A
Health Discovery0000N/A

Volatility and Risk

Network-1 Technologies has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500. Comparatively, Health Discovery has a beta of 3.31, meaning that its share price is 231% more volatile than the S&P 500.

Earnings & Valuation

This table compares Network-1 Technologies and Health Discovery's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Network-1 Technologies$4.40 million18.47$-1,710,000.00N/AN/A
Health DiscoveryN/AN/A$-760,000.00N/AN/A

Health Discovery has lower revenue, but higher earnings than Network-1 Technologies.

Profitability

This table compares Network-1 Technologies and Health Discovery's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Network-1 Technologies39.59%17.50%16.60%
Health DiscoveryN/A120.67%32.77%

Research Frontiers (NASDAQ:REFR) and Health Discovery (OTCMKTS:HDVY) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.

Valuation & Earnings

This table compares Research Frontiers and Health Discovery's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Research Frontiers$830,000.0084.65$-2,340,000.00N/AN/A
Health DiscoveryN/AN/A$-760,000.00N/AN/A

Health Discovery has lower revenue, but higher earnings than Research Frontiers.

Profitability

This table compares Research Frontiers and Health Discovery's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Research Frontiers-270.69%-58.92%-50.26%
Health DiscoveryN/A120.67%32.77%

Volatility and Risk

Research Frontiers has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Health Discovery has a beta of 3.31, meaning that its stock price is 231% more volatile than the S&P 500.

Insider and Institutional Ownership

18.0% of Research Frontiers shares are owned by institutional investors. Comparatively, 0.1% of Health Discovery shares are owned by institutional investors. 7.0% of Research Frontiers shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Research Frontiers and Health Discovery, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Research Frontiers0000N/A
Health Discovery0000N/A

Summary

Health Discovery beats Research Frontiers on 5 of the 8 factors compared between the two stocks.


Health Discovery Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Acacia Research logo
ACTG
Acacia Research
0.8$5.85-1.5%$290.51 million$29.78 million-5.47News Coverage
Gap Up
VirnetX logo
VHC
VirnetX
0.5$4.02-0.7%$285.66 million$302.64 million-6.28News Coverage
PCOA
Pendrell
0.2$227,000.00-0.0%$220.19 millionN/A0.00
Quarterhill logo
QTRHF
Quarterhill
1.4$1.90-1.1%$216.64 million$107.89 million15.83Short Interest Decrease
News Coverage
Network-1 Technologies logo
NTIP
Network-1 Technologies
0.9$3.37-0.3%$81.28 million$4.40 million9.11
Research Frontiers logo
REFR
Research Frontiers
0.5$2.22-0.0%$70.26 million$830,000.00-22.20Gap Down
Xcel Brands logo
XELB
Xcel Brands
0.8$2.23-3.6%$43.11 million$29.45 million-2.93Gap Up
Micro Imaging Technology logo
MMTC
Micro Imaging Technology
0.7$0.85-11.8%$19.59 millionN/A0.00Gap Down
MMTRS
Mills Music Trust
0.3$41.00-1.4%$11.48 millionN/A0.00
RLLY
ARC Group
0.0$0.22-0.0%$1.63 million$9.50 million0.00News Coverage
High Trading Volume
ARCK
ARC Group
0.5$0.22-0.0%$1.61 million$9.50 million0.00High Trading Volume
ICTPU
American Restaurant Partners
0.7$1,660.00-0.0%$0.00N/A0.00
ECGP
Envit Capital Group
0.4$0.00-0.0%$0.00N/A0.00
PTSC
Patriot Scientific
0.4$1.75-0.6%$0.00N/A0.00
This page was last updated on 7/25/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.